ACMG Factor V. Leiden Working Group / Genetics EGAPP Working Group / Clinical Genetic Laboratories / Practice Center / Agency for Health / EGAPP Working Group / Agency for Healthcare Research / Merck & Co. Inc. / GE / Kao / /
Continent
Europe / /
Country
Canada / Australia / United Kingdom / United States / / /
Facility
American College of Chest Physicians / Medical College of Wisconsin / University of Utah / Science University / American College of Medical Genetics Consensus Statement / College of American Pathologists / Emory University / University of Washington / University of Colorado School / American College / American College of Medical Genetics Standards / The American College of Chest Physicians / Brown University / Laboratory Medicine / Tufts Medical Center / American College of Chest Physicians EvidenceBased Clinical Practice Guidelines / The Johns Hopkins University Evidence-Based Practice Center / University of Arizona College of Medicine / Johns Hopkins University / Blue Shield Association Technology Evaluation Center / /
IndustryTerm
search terms / genomic applications / Evidence report/technology assessment / human services / youngest age / therapy for venous thromboembolic disease / age groups / microarray technologies / unusual body site / /
MarketIndex
VTE / /
MedicalCondition
recurrent venous thromboembolism / arterial thrombosis / JE / V Leiden thrombophilia / acute deep venous thrombosis / disorder / venous thromboembolic disease / postthrombotic syndrome / pregnancy-related venous thrombosis / heritable thrombophilia / inherited thrombophilia / lifetime deep vein thrombosis / severe inherited thrombophilia / pulmonary arteries / severe postthrombotic syndrome / pathologic thromboses / cancer / deep venous thrombosis / Thromboembolism / leg ulcers / deep vein thrombosis / idiopathic venous thromboembolism / chronic disease / activated Protein C resistance / lifetime venous thromboembolism / uncomplicated deep venous thrombosis / primary chronic anticoagulant administration / massive pulmonary embolism requiring thrombolytic treatment / Thrombophilia / medical disorders / hypercoagulability / leg pain / thromboembolic disorders / familial thrombophilia / mild-to-moderate postthrombotic syndrome / pulmonary embolism / MS / lupus / Protein S deficiencies / venous hypertension / venous thrombosis / proximal deep venous thrombosis / APC resistance / autoimmune disease / thrombophilia mutations / Venous thromboembolism / thrombophilia testing / acute pulmonary embolism / thrombophilias / thrombosis / Eriksson H. Recurrent venous thromboembolism / recurrent thrombosis / syndrome / /
University of Washington / US Department of Health and Human Services / World Health Organization / The Johns Hopkins University / College of American Pathologists / American College of Chest Physicians / American College of Chest Physicians EvidenceBased Clinical Practice Guidelines / Medical School / Public Policy Center / Medical College of Wisconsin / University of Arizona College of Medicine / Emory University / Nell Hodgson Woodruff School of Nursing / University of Utah / Department of Medicine / Johns Hopkins University Evidence-Based Practice Center / Advisory Committee on Genetics Health / Cardiovascular Disease Educational and Research Trust / The American College / Medical Center / Blue Cross/Blue Shield Association Technology Evaluation Center / Established Agency for Healthcare Research / Washington State Department / Clinical Genetics Service / British Committee on Standards / Brown University / Thrombosis / and French Society of Vascular Medicine55 / Department of Pediatrics / Johns Hopkins University / Colorado Department of Public Health and Environment / Oregon Health & Science University / Centers for Disease Control and Prevention / University of Colorado School of Medicine / Los Angeles County Department of Public Health / Advisory Committee on Genetics / Mediterranean League on Thromboembolism54 / Memorial Sloan-Kettering Cancer Center / office of Public Health Genomics / Department of Family Medicine / Division of Clinical Decision Making / Informatics and Telemedicine / Department of Pathology and Laboratory Medicine / European Genetics Foundation / Institute for Public Health Genetics / Agency for Healthcare Research and Quality / International Union of Angiology / American College of Medical Genetics Consensus Statement / /
Person
Steven Teutsch / Van Cott / Stephen G. Pauker / Kenneth Offit / Nell Hodgson / Arch Pathol / Ora L. Strickland / Celia Kaye / Joan A. Scott / James E. Haddow / Maxine Hayes / Alfred O. Berg / Doug Campos-Outcalt / Rosa M. Acute / David L. Veenstra / Arch Intern / Jeffrey Botkin / Carolyn Sue Richards / Ned Calonge / Margaret Piper / Roger D. Klein / /
Position
secretary of health / Prime Minister / physician / Butler / Secretary / Carpenter / Ridker PM / Chair / /
Product
Vitamin K / /
ProvinceOrState
Utah / Arizona / Colorado / Wisconsin / Oregon / Los Angeles County / /
EGAPP RECOMMENDATION STATEMENT Recommendations from the EGAPP Working Group: Routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism